Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease and Letter: faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Authors’ reply

I. Ahmed(University of Utah), C Probert(Bristol Royal Infirmary), Ben de Lacy Costello(University of the West of England), Norman Ratcliffe(University of the West of England), Rosemary Greenwood
Alimentary Pharmacology & Therapeutics
May 3, 2016
Cited by 2


Related Papers